Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wolkenstein

Showing results (71-80 of 230) with videos related to

Pageof 23
Sort By:
Pharmaceutical Development and Technology|September 17, 2024
Preformulation evaluation of selumetinib for topical application: skin distribution and photodegradation analysis using MALDI imaging and LC-MS/MSEdith Nicol, Bernard Do, Marina Vignes, et al.
Plastic and Reconstructive Surgery|March 29, 2016
Low Rates of Blood Transfusion in Elective Resections of Neurofibromas in a Cohort Study: Neurofibroma Length as a Predictor of Transfusion RequirementMikael Hivelin, Benoit Plaud, Francois Hemery, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2004
Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cellsAmal Nassif, Armand Bensussan, Laurence Boumsell, et al.
Acta Dermato-Venereologica|September 10, 2015
Clinical Characteristics of Pruritus in Neurofibromatosis 1Emilie Brenaut, Constance Nizery-Guermeur, Séverine Audebert-Bellanger, et al.
European Journal of Human Genetics : EJHG|February 2, 2023
Comment on Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1Laurence Pacot, Albain Chansavang, Sébastien Jacques, et al.
Dermatology (Basel, Switzerland)|February 10, 2015
Treatment of neurofibromas with a carbon dioxide laser: a retrospective cross-sectional study of 106 patientsCécile Méni, Emilie Sbidian, Jean Christophe Moreno, et al.
Urologia Internationalis|March 8, 2018
Bladder Dysfunction in Children with Neurofibromatosis Type I: Report of Four Cases and Review of the LiteratureAurore Bouty, Eric Dobremez, Luke Harper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosisPascale Lévy, Ivan Bièche, Karen Leroy, et al.
Acta Dermato-Venereologica|November 5, 2014
Consequences of acne on stress, fatigue, sleep disorders and sexual activity: a population-based studyLaurent Misery, Pierre Wolkenstein, Jean-Michel Amici, et al.
Journal of the American Academy of Dermatology|November 17, 2025
Risk of immunogenicity during infliximab therapy in hidradenitis suppurativa compared with other chronic inflammatory diseases: A retrospective monocentric cohortCamille Barral, Ramatoulaye Ndiaye, Christina Bergqvist, et al.
Pageof 23

Showing results (71-80 of 230) with videos related to

Sort By:
Pageof 23
Pharmaceutical Development and Technology|September 17, 2024
Preformulation evaluation of selumetinib for topical application: skin distribution and photodegradation analysis using MALDI imaging and LC-MS/MSEdith Nicol, Bernard Do, Marina Vignes, et al.
Plastic and Reconstructive Surgery|March 29, 2016
Low Rates of Blood Transfusion in Elective Resections of Neurofibromas in a Cohort Study: Neurofibroma Length as a Predictor of Transfusion RequirementMikael Hivelin, Benoit Plaud, Francois Hemery, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2004
Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cellsAmal Nassif, Armand Bensussan, Laurence Boumsell, et al.
Acta Dermato-Venereologica|September 10, 2015
Clinical Characteristics of Pruritus in Neurofibromatosis 1Emilie Brenaut, Constance Nizery-Guermeur, Séverine Audebert-Bellanger, et al.
European Journal of Human Genetics : EJHG|February 2, 2023
Comment on Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1Laurence Pacot, Albain Chansavang, Sébastien Jacques, et al.
Dermatology (Basel, Switzerland)|February 10, 2015
Treatment of neurofibromas with a carbon dioxide laser: a retrospective cross-sectional study of 106 patientsCécile Méni, Emilie Sbidian, Jean Christophe Moreno, et al.
Urologia Internationalis|March 8, 2018
Bladder Dysfunction in Children with Neurofibromatosis Type I: Report of Four Cases and Review of the LiteratureAurore Bouty, Eric Dobremez, Luke Harper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosisPascale Lévy, Ivan Bièche, Karen Leroy, et al.
Acta Dermato-Venereologica|November 5, 2014
Consequences of acne on stress, fatigue, sleep disorders and sexual activity: a population-based studyLaurent Misery, Pierre Wolkenstein, Jean-Michel Amici, et al.
Journal of the American Academy of Dermatology|November 17, 2025
Risk of immunogenicity during infliximab therapy in hidradenitis suppurativa compared with other chronic inflammatory diseases: A retrospective monocentric cohortCamille Barral, Ramatoulaye Ndiaye, Christina Bergqvist, et al.
Pageof 23